FDCC
CRSP icon

Foster Dykema Cabot & Co’s CRISPR Therapeutics CRSP Stock Holding History

Foster Dykema Cabot & Co’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		$0 Hold
10
– – ﹤0.01% 342
2023
Q2 		$1K Hold
10
– – ﹤0.01% 366
2023
Q1 		$0 Buy
+10
New – ﹤0.01% 240